US 6670376
Aryl aniline &bgr;2 adrenergic receptor agonists
expired A61PA61P11/00A61P11/06
Quick answer
US patent 6670376 (Aryl aniline &bgr;2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P15/06